{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:26:24Z","timestamp":1793409984713,"version":"4.5.0"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.trim.2021.101495","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T11:40:19Z","timestamp":1636544419000},"page":"101495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses"],"prefix":"10.1016","volume":"70","author":[{"given":"Elahe","family":"Aleebrahim-Dehkordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Molavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Deravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Fazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mohebalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooneh","family":"Koochaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parnian","family":"Shobeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hasanpour-Dehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2007.02719.x","article-title":"Immunological decision-making: how does the immune system decide to mount a helper T-cell response?","volume":"123","author":"Kaiko","year":"2008","journal-title":"Immunology."},{"issue":"8","key":"10.1016\/j.trim.2021.101495_bb0010","first-page":"1086","article-title":"T follicular helper (Tfh) cells in normal immune responses and in allergic disorders","volume":"71","author":"Varricchi","year":"2016"},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.it.2013.01.001","article-title":"T follicular helper cell diversity and plasticity","volume":"34","author":"Cannons","year":"2013","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.trim.2021.101495_bb0030","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.4049\/jimmunol.181.10.7428-a","article-title":"CD8 T cells utilize TRAIL to control influenza virus infection","volume":"15","author":"Brincks","year":"2008","journal-title":"J Immunol November"},{"key":"10.1016\/j.trim.2021.101495_bb0035","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern. Med. Rev."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4110\/in.2016.16.1.1","article-title":"Regulation of Th2 Cell Immunity by Dendritic Cells","volume":"16","author":"Na","year":"2016","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2009.07.003","article-title":"STAT3 in CD4+ T helper Cell differentiation and Inflammatory Diseases","volume":"47","author":"Egwuagu","year":"2009","journal-title":"Cytokine."},{"key":"10.1016\/j.trim.2021.101495_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","article-title":"The full spectrum of human naive T cells","volume":"18","author":"van den Broek","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2014.00487","article-title":"The differentiation of CD4+ T-helper cell subsets in the context of helminth parasite infection","volume":"5","author":"Bouchery","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/intimm\/dxw006","article-title":"CD4+ T-cell subsets in inflammatory diseases: beyond the T h 1\/T h 2 paradigm","volume":"28","author":"Hirahara","year":"2016","journal-title":"Int. Immunol."},{"issue":"269","key":"10.1016\/j.trim.2021.101495_bb0065","doi-asserted-by":"crossref","first-page":"269rv1","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3390\/cells9030531","article-title":"Memory CD4+ T cells in immunity and autoimmune diseases","volume":"9","author":"Raphael","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.trim.2021.101495_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"18","key":"10.1016\/j.trim.2021.101495_bb0080","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10228","key":"10.1016\/j.trim.2021.101495_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","volume":"395","author":"Anderson","year":"2020","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0090","first-page":"767","article-title":"Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2","volume":"54","author":"Patil","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0095","first-page":"259","article-title":"The 2009 influenza A virus subtype H1N1 pandemic, a glance from Greece","volume":"24","author":"Tsoucalas","year":"2016","journal-title":"Infez Med."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0100","first-page":"135","article-title":"H1N1 Influenza A infection","volume":"13","author":"Dotis","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.trim.2021.101495_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmicb.2012.00117","article-title":"Cell receptors for influenza A viruses and the innate immune response","volume":"3","author":"Ramos","year":"2012","journal-title":"Front. Microbiol."},{"issue":"19","key":"10.1016\/j.trim.2021.101495_bb0110","doi-asserted-by":"crossref","first-page":"10704","DOI":"10.1128\/JVI.01166-12","article-title":"Entry of influenza A virus with a \u03b12,6-linked sialic acid binding preference requires host fibronectin","volume":"86","author":"Leung","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.trim.2021.101495_bb0115","doi-asserted-by":"crossref","first-page":"2003988","DOI":"10.1183\/13993003.03988-2020","article-title":"Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells","author":"Schweitzer","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.trim.2021.101495_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","article-title":"Coinfection with influenza A virus enhances SARS-CoV-2 infectivity","volume":"31","author":"Bai","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.trim.2021.101495_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12985-021-01594-0","article-title":"Influenza co-infection associated with severity and mortality in COVID-19 patients","volume":"18","author":"Alosaimi","year":"2021","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"YH. Zhou, Y. ZQ. The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: An overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.trim.2021.101495_bb0140","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3389\/fimmu.2018.01377","article-title":"Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment","volume":"9","author":"Tahamtan","year":"2018","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.trim.2021.101495_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140329","article-title":"Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections","volume":"5","author":"Remy","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.trim.2021.101495_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00001432-200306000-00003","article-title":"Toll-like receptors and T-helper-1\/T-helper-2 responses","volume":"16","author":"Dabbagh","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.trim.2021.101495_bb0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/ar85","article-title":"Cell fate decision: T-helper 1 and 2 subsets in immune responses","volume":"2","author":"Dong","year":"2000","journal-title":"Arthritis Res Ther"},{"issue":"14","key":"10.1016\/j.trim.2021.101495_bb0160","article-title":"Animal communication: when i\u2019m calling you, will you answer too?","volume":"27","author":"Vickers","year":"2017"},{"key":"10.1016\/j.trim.2021.101495_bb0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2 specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Bert","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.trim.2021.101495_bb0170","article-title":"Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19","author":"Adamo","year":"2020","journal-title":"bioRxiv."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0175","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2005-02-0456","article-title":"IL-6 blocks a discrete early step in lymphopoiesis","volume":"106","author":"Maeda","year":"2005","journal-title":"Blood"},{"issue":"49","key":"10.1016\/j.trim.2021.101495_bb0180","doi-asserted-by":"crossref","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","article-title":"Comprehensive mapping of immune perturbations associated with severe COVID-19","volume":"15","author":"Kuri-Cervantes","year":"2020","journal-title":"Sci. Immunol"},{"key":"10.1016\/j.trim.2021.101495_bb0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.trim.2021.101495_bb0190","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/vaccines9030238","article-title":"Correlates of vaccine-induced protection against SARS-CoV-2","volume":"9","author":"Koch","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.trim.2021.101495_bb0200","first-page":"1","article-title":"Covid-19 interstitial pneumonia: histological and immunohistochemical features on cryobiopsies","volume":"16","author":"Doglioni","year":"2021","journal-title":"Respiration."},{"key":"10.1016\/j.trim.2021.101495_bb0205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0210","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S2665-9913(21)00034-5","article-title":"Type I interferon, anti-interferon antibodies, and COVID-19","volume":"3","author":"Calabrese","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.trim.2021.101495_bb0215","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0220","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.trim.2021.101495_bb0225","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.1601542","article-title":"Protective T cell responses featured by concordant recognition of middle east respiratory syndrome coronavirus-derived CD8+ T cell epitopes and host MHC","volume":"198","author":"Liu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0230","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.trim.2021.101495_bb0235","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.trim.2021.101495_bb0240","article-title":"Intrafamilial exposure to SARS-CoV-2 induces cellular immune response without seroconversion","author":"Gallais","year":"2020","journal-title":"Medrxiv."},{"key":"10.1016\/j.trim.2021.101495_bb0245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.trim.2021.101495_bb0250","article-title":"SARS-CoV- 2-Specific T cells exhibit phenotypic features of robust helper function, lack of terminal differentiation, and high proliferative potential","volume":"1","author":"Neidleman","year":"2020","journal-title":"Cell Rep Med."},{"issue":"6","key":"10.1016\/j.trim.2021.101495_bb0255","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00277-020-04066-7","article-title":"Signals of T h 2 immune response from COVID-19 patients requiring intensive care","volume":"99","author":"Luca","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.trim.2021.101495_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624483","article-title":"T-Helper cell subset response is a determining factor in COVID-19 progression","volume":"11","author":"Gil-Etayo","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.trim.2021.101495_bb0265","first-page":"1","article-title":"Toward an understanding of regulatory T cells in COVID-19: a systemic review","volume":"93","author":"Rahimdazeh","year":"2021","journal-title":"JMedVirol."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0270","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/1744666X.2020.1750954","article-title":"Immune-epidemiological parameters of the novel coronavirus - a perspective","volume":"16","author":"Saghazadeha","year":"2020","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri820","article-title":"No one is naive: the significance of heterologous T-cell immunity","volume":"2","author":"Welsh","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/Type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.trim.2021.101495_bb0285","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent Symptoms in Patients After Acute COVID-19","volume":"11","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.trim.2021.101495_bb0290","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0295","article-title":"An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19","author":"John","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.trim.2021.101495_bb0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245532","article-title":"T cell response to SARS-CoV-2 infection in humans: A systematic review","volume":"16","author":"Shrotri","year":"2021","journal-title":"PLoS One"},{"issue":"2020","key":"10.1016\/j.trim.2021.101495_bb0310","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.trim.2021.101495_bb0315","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0320","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3389\/fimmu.2020.02033","article-title":"The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108487","article-title":"Type 3 hypersensitivity in COVID-19 vasculitis","author":"Roncati","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109824","article-title":"What about the original antigenic sin of the humans versus SARS-CoV-2?","volume":"142","author":"Roncati","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"7","key":"10.1016\/j.trim.2021.101495_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254367","article-title":"Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses","volume":"16","author":"Ravindran","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0340","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/infdis\/jix328","article-title":"Dysregulated T-helper type 1 (Th1): Th2 cytokine profile and poor immune response in pregnant ferrets infected with 2009 pandemic influenza A (H1N1) virus","volume":"217","author":"Yoon","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.trim.2021.101495_bb0345","first-page":"65","article-title":"Impact of COVID-19 social distancing regulations on outpatient diagnostic imaging volumes and no-show rates","volume":"76","author":"Doshi","year":"2021"},{"issue":"06","key":"10.1016\/j.trim.2021.101495_bb0350","first-page":"536","article-title":"Diversity of Th1\/Th2 immunity in mice with acute lung injury induced by the H1N1 influenza virus and lipopolysaccharides","volume":"13","author":"Liu","year":"2019","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.trim.2021.101495_bb0355","first-page":"2016","article-title":"A de-O-acylated lipooligosaccharide-based adjuvant system promotes antibody and Th1-type immune responses to H1N1 pandemic influenza vaccine in mice","author":"Ryu","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.trim.2021.101495_bb0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/mi.2012.2","article-title":"Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung","volume":"5","author":"Dienz","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.593595","article-title":"Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)","volume":"12","author":"Chore\u00f1o-Parra","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0370","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"827","key":"10.1016\/j.trim.2021.101495_bb0375","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.trim.2021.101495_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0385","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clinimag.2020.04.042","article-title":"Preliminary CT findings of coronavirus disease 2019 COVID-19","volume":"65","author":"Cui","year":"2020","journal-title":"Clin. Imaging"},{"issue":"11","key":"10.1016\/j.trim.2021.101495_bb0395","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/s41379-020-0603-3","article-title":"A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression","volume":"33","author":"Polak","year":"2020","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0400","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-2119","article-title":"T helper 1\/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol","volume":"117","author":"Pinto","year":"2006","journal-title":"Pediatrics."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0405","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1172\/JCI118287","article-title":"HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release","volume":"96","author":"Koziel","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.trim.2021.101495_bb0410","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.6156","article-title":"Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients","volume":"12","author":"Sofian","year":"2012","journal-title":"Hepat. Mon."},{"issue":"8","key":"10.1016\/j.trim.2021.101495_bb0415","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1128\/jvi.70.8.5230-5235.1996","article-title":"Interleukin-4 causes delayed virus clearance in influenza virus-infected mice","volume":"70","author":"Moran","year":"1996","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.trim.2021.101495_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003615","article-title":"Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection","volume":"9","author":"Gorski","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.trim.2021.101495_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8539294","article-title":"The expression of IL-6, TNF-\u03b1, and MCP-1 in respiratory viral infection in acute exacerbations of chronic obstructive pulmonary disease","author":"Zheng","year":"2017","journal-title":"J Immunol Res"},{"issue":"11","key":"10.1016\/j.trim.2021.101495_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005122","article-title":"Selective inhibitor of nuclear export (SINE) compounds alter New World alphavirus capsid localization and reduce viral replication in mammalian cells","volume":"10","author":"Lundberg","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0435","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jcla.2060","article-title":"Cytokine serum levels in patients with chronic HCV infection","volume":"16","author":"Spanakis","year":"2002","journal-title":"J. Clin. Lab. Anal."},{"issue":"8","key":"10.1016\/j.trim.2021.101495_bb0440","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1995-7645(13)60108-X","article-title":"Cytokine levels in patients with chikungunya virus infection","volume":"6","author":"Chirathaworn","year":"2013","journal-title":"Asian Pac J Trop Med"},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0445","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/clinids\/18.2.194","article-title":"Serum levels of interleukin-1\u03b1, interleukin-1\u03b2, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis","volume":"18","author":"Torre","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0450","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/infdis\/jiv123","article-title":"Factors associated with plasma IL-6 levels during HIV infection","volume":"212","author":"Borges","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.trim.2021.101495_bb0455","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/jmv.24864","article-title":"Cytokine response in Crimean-Congo hemorrhagic fever virus infection","volume":"89","author":"Erg\u00f6n\u00fcl","year":"2017","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.trim.2021.101495_bb0460","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/mi.2011.34","article-title":"Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses","volume":"4","author":"Rollenhagen","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"1057","key":"10.1016\/j.trim.2021.101495_bb0465","article-title":"The Role of Interleukin 6 During Viral Infections","volume":"10","author":"Velazquez-Salinas","year":"2019","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0470","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tips.2016.01.004","article-title":"JE. Bourke, R. Vlahos. Targeting the IL-33\/IL-13 axis for respiratory viral infections","volume":"37","author":"Donovan","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.trim.2021.101495_bb0475","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1128\/JVI.79.10.6441-6448.2005","article-title":"Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection","volume":"79","author":"Schmitz","year":"2005","journal-title":"J. Virol."},{"issue":"2015","key":"10.1016\/j.trim.2021.101495_bb0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri3803","article-title":"brief history of T cell helps to B cells","volume":"15","author":"Crotty","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0485","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jcp.21597","article-title":"Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens","volume":"218","author":"Arrenberg","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.trim.2021.101495_bb0490","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","article-title":"Invariant natural killer T cells: bridging innate and adaptive immunity","volume":"343","author":"Van Kaer","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.trim.2021.101495_bb0495","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2020.02025","article-title":"T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh Cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"7258","key":"10.1016\/j.trim.2021.101495_bb0500","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","article-title":"Th1 and Th2 responses: what are they?","volume":"321","author":"Berger","year":"2000","journal-title":"Bmj."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0505","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/rr40","article-title":"Th2 cytokines and asthma - Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists","volume":"2","author":"Steinke","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.trim.2021.101495_bb0510","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420966497","article-title":"Immune system changes during COVID-19 recovery play key role in determining disease severity","volume":"34","author":"Fathi","year":"2020","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"48","key":"10.1016\/j.trim.2021.101495_bb0515","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"26","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.trim.2021.101495_bb0520","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","article-title":"T cell responses in patients with COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0525","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/s41598-019-39048-x","article-title":"The diagnostic accuracy of Th1 (IFN-\u03b3, TNF-\u03b1, and IL-2) and Th2 (IL-4, IL-6 and IL-10) cytokines response in AFB microscopy smear negative PTB- HIV co-infected patients","volume":"9","author":"Kisuya","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0530","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF02591635","article-title":"Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease","volume":"21","author":"Romagnani","year":"1992","journal-title":"Int J Clin Lab Res."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0535","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.4110\/in.2018.18.e33","article-title":"Direct antiviral mechanisms of interferon-gamma","volume":"18","author":"Kang","year":"2018","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0540","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1128\/JVI.76.3.1071-1076.2002","article-title":"Tumor necrosis factor alpha exerts powerful anti-influenza virus effects in lung epithelial cells","volume":"76","author":"Seo","year":"2002","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0545","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/viro.2000.0442","article-title":"Cytokine-mediated control of viral infections","volume":"273","author":"Guidotti","year":"2000","journal-title":"Virology."},{"issue":"9","key":"10.1016\/j.trim.2021.101495_bb0550","first-page":"e23","article-title":"Understanding the T cell immune response in SARS coronavirus infection","volume":"1","author":"Oh","year":"2012","journal-title":"Emerg Microbes Infect"},{"issue":"23","key":"10.1016\/j.trim.2021.101495_bb0555","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0560","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Te","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2021.101495_bb0565","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"315","key":"10.1016\/j.trim.2021.101495_bb0570","first-page":"315ra189","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"25","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0575","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.trim.2021.101495_bb0580","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s11427-020-1661-4","article-title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China","volume":"63","author":"Hu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.trim.2021.101495_bb0585","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.trim.2021.101495_bb0590","first-page":"3377","article-title":"The optimal radiation dose to induce robust systemic anti-tumor immunity","volume":"19","author":"Poleszczuk","year":"2018"},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0595","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/rheumatology\/kev403","article-title":"Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis","volume":"55","author":"Bonelli","year":"2016","journal-title":"Rheumatology."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0600","doi-asserted-by":"crossref","first-page":"2002182","DOI":"10.1183\/13993003.02182-2020","article-title":"Potential of regulatory T-cell-based therapies in the management of severe COVID-19","volume":"56","author":"Stephen-Victor","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.trim.2021.101495_bb0605","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/08830185.2018.1465943","article-title":"Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis","volume":"37","author":"Langdon","year":"2018","journal-title":"Int. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.trim.2021.101495_bb0610","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.arcmed.2020.06.012","article-title":"Targeting cytokine storm to manage patients with COVID-19: A Mini-Review","volume":"51","author":"Roshanravan","year":"2020","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0615","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.fmre.2021.01.011","article-title":"Current progress and challenges in the design and development of a successful COVID-19 vaccine","volume":"1","author":"Li","year":"2021","journal-title":"J. Fundam. Res."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0974-777X.77299","article-title":"Fundamentals of vaccine immunology","volume":"3","author":"Clem","year":"2011","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.trim.2021.101495_bb0625","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy","author":"Apostolidis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0630","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1302503","article-title":"Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults","volume":"193","author":"Herati","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0635","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2021.101495_bb0640","article-title":"Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination","author":"Painter","year":"2021","journal-title":"BioRxiv."},{"key":"10.1016\/j.trim.2021.101495_bb0645","article-title":"Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals","author":"Samanovic","year":"2021","journal-title":"MedRxiv."},{"key":"10.1016\/j.trim.2021.101495_bb0650","first-page":"eabj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.Sci","volume":"6","author":"Geers","year":"2021","journal-title":"Immunol"},{"issue":"288","key":"10.1016\/j.trim.2021.101495_bb0655","doi-asserted-by":"crossref","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 Vaccine: A comprehensive status report","volume":"15","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.trim.2021.101495_bb0660","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape","volume":"19","author":"Thanh","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.trim.2021.101495_bb0665","first-page":"221","article-title":"Efficacy and safety of COVID-19 vaccines: a systematic review","volume":"15","author":"Xing","year":"2021","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.trim.2021.101495_bb0670","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.trim.2021.101495_bb0675","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature."},{"issue":"16","key":"10.1016\/j.trim.2021.101495_bb0680","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0685","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41467-021-21634-1","article-title":"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates","volume":"12","author":"Liang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trim.2021.101495_bb0690","article-title":"Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine","author":"Sahin","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.trim.2021.101495_bb0695","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0700","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.trim.2021.101495_bb0705","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-021-00356-x","article-title":"Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic","volume":"6","author":"Mendon\u00e7a","year":"2021","journal-title":"npj Vaccines."},{"key":"10.1016\/j.trim.2021.101495_bb0710","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.trim.2021.101495_bb0715","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.trim.2021.101495_bb0720","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fmicb.2020.00658","article-title":"The current and future state of vaccines, antivirals and gene therapies against emerging coronaviruses","volume":"11","author":"Tse","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.trim.2021.101495_bb0725","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0730","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular Helper T Cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0735","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2021.101495_bb0740","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"immunity."},{"key":"10.1016\/j.trim.2021.101495_bb0745","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of Protection Induced by Vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0750","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","article-title":"A possible role for B cells in COVID-19? lesson from patients with agammaglobulinemia","volume":"146","author":"Quinti","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0755","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/pai.13263","article-title":"Two X-linked Agammaglobulinemia Patients Develop Pneumonia as COVID-19 Manifestation but Recover","volume":"31","author":"Soresina","year":"2020","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0760","article-title":"A Prefusion SARS-CoV-2 Spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates","author":"Vogel","year":"2020","journal-title":"Biorxiv."},{"issue":"2","key":"10.1016\/j.trim.2021.101495_bb0765","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.trim.2021.101495_bb0770","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A single immunization with nucleoside-modified mrna vaccines elicits strong cellular and humoral Immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2021.101495_bb0775","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the MRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trim.2021.101495_bb0780","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 MRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.trim.2021.101495_bb0785","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ni.1715","article-title":"Cytokine-Secreting Follicular T Cells Shape the Antibody Repertoire","volume":"10","author":"Reinhardt","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trim.2021.101495_bb0790","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific Helper T Cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.trim.2021.101495_bb0795","first-page":"1","article-title":"Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza","volume":"6","author":"Bao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.trim.2021.101495_bb0800","first-page":"2795","article-title":"SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara","volume":"25","author":"Greco","year":"2021","journal-title":"Italy. Eur Rev Med Pharmacol Sci."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327421001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:00:37Z","timestamp":1760810437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327421001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":160,"alternative-id":["S0966327421001350"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2021.101495","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2021.101495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101495"}}